Requip

Salt: Ropinirole
Therapeutic Description: Antiparkinsonism Preps
Category: Dopamine agonist, dopaminergic agent.
Pregnancy: Risk cannot be ruled out.
Lactation: Contraindicated or not recommended.
Contraindications: Severe renal or severe hepatic impairment.
Precautions: Moderate hepatic impairment, severe cardiovascular disease, psychosis. Withdraw gradually.
Monotherapy or as an adjunct to levodopa in idiopathic Parkinson's disease. Symptomatic treatment of moderate to severe idiopathic restless legs syndrome.
Parkinson's disease: Adults: Week 1: 0.25 mg three times daily with meals. Week 2: 0.5 mg three times daily. Week 3: 0.75 mg three times daily. Week 4: 1 mg three times daily. If necessary, continue to titrate in weekly increments of up to 3 mg dai
Ciprofloxacin, enoxacin, fluvoxamine, HRT, starting or stopping smoking, neuroleptics, sulpiride, metoclopramide.
GI upset, nausea, abdominal pain, somnolence, leg oedema, nervousness, dizziness, fatigue, syncope, hypotension, bradycardia, dyskinesias, hallucinations, confusion. Rarely, sudden onset of sleep (warn patient).
Strength Pack Size PKR
0.25 mg21's290.00
1 mg21's720.00
2 mg21's1000.00

Your medicine formula resulted in the following types of medicine type. Please select to proceed.